Antineoplastic isoliquirtigenin tablet

technical field [0001] The invention relates to the field of pharmacy, in particular to an anti-tumor isoliquiritigenin tablet. Suitable for human cervical cancer cells, prostate cancer cells, S 180 Tumor lines, Ehrlich ascites cancer cells, human A549 lung cancer cells, oral epidermal cancer KB cells, KM-12 colon cancer cells, BEL-7402 liver cancer cells and MCF-7 breast cancer cells. Background technique [0002] 1. Tumor has become the number one killer threatening human health [0003] Tumor is one of the common and frequently-occurring diseases that seriously threaten human life, and its incidence rate is increasing year by year. According to the survey of the World Health Organization, nearly 10 million cancer patients are newly discovered every year in the world. Nearly 7 million people die from cancer every year. Recent statistics show that about 20 million cancer patients are newly discovered in my country every year, and nearly 1.5 million people die of cancer....